NewsWhore
05-11-2009, 01:20 AM
<img alt="" height="1" width="1">
Botox Maker Allergan Faces Nestle-L'Oreal Challenge in Europe (http://news.google.com/news/url?sa=T&ct=us/1-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601100%26sid%3DaoETYzMjS.Zc%26refer%3Dgermany&cid=0&ei=s7cHSsHcIYvGsgbU7-XuCA&usg=AFQjCNG9euEi3_2Iw3HWNcGZYMPK9IHweQ)
Bloomberg
Allergan's Botox sales rose 0.7 percent excluding currency movements in the first quarter, down from a 7.2 percent pace in 2008. New rules may constrain Allergan as well. Last month, US regulators required makers of botulinum toxins to strengthen their ...
More... (http://news.google.com/news/url?sa=T&ct=us/1-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601100%26sid%3DaoETYzMjS.Zc%26refer%3Dgermany&cid=0&ei=s7cHSsHcIYvGsgbU7-XuCA&usg=AFQjCNG9euEi3_2Iw3HWNcGZYMPK9IHweQ)
Botox Maker Allergan Faces Nestle-L'Oreal Challenge in Europe (http://news.google.com/news/url?sa=T&ct=us/1-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601100%26sid%3DaoETYzMjS.Zc%26refer%3Dgermany&cid=0&ei=s7cHSsHcIYvGsgbU7-XuCA&usg=AFQjCNG9euEi3_2Iw3HWNcGZYMPK9IHweQ)
Bloomberg
Allergan's Botox sales rose 0.7 percent excluding currency movements in the first quarter, down from a 7.2 percent pace in 2008. New rules may constrain Allergan as well. Last month, US regulators required makers of botulinum toxins to strengthen their ...
More... (http://news.google.com/news/url?sa=T&ct=us/1-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601100%26sid%3DaoETYzMjS.Zc%26refer%3Dgermany&cid=0&ei=s7cHSsHcIYvGsgbU7-XuCA&usg=AFQjCNG9euEi3_2Iw3HWNcGZYMPK9IHweQ)